Nanjing Vazyme Biotech's Unit Gets Approval to Sell Two Medical Devices in Europe
Nanjing Vazyme Biotech's Unit Gets Approval to Sell Two Medical Devices in Europe
南京華澤生物科技的子公司獲得在歐洲賣出兩種醫療設備的批准
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊